#72
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
I need more information to write an accurate explanation. The summary appears to be truncated and doesn’t include the key findings about why older adults are turning to cannabis edibles or what the study revealed. Could you provide the complete article summary or main findings so I can explain the clinical significance accurately?
A University of Utah Health and University of Colorado Boulder study documents a growing trend of cannabis use among older adults, with particular attention to edible consumption in this population. The research suggests that older adults are increasingly turning to cannabis products, particularly edibles, likely motivated by chronic pain management, sleep disturbance, and other age-related conditions where traditional pharmaceuticals may be inadequate or poorly tolerated. Understanding the specific preferences and patterns of cannabis use in geriatric populations is clinically important because older adults often have complex medication interactions, altered pharmacokinetics due to age-related physiologic changes, and heightened sensitivity to psychoactive effects. The popularity of edibles among this demographic raises particular clinical concerns regarding dosing accuracy, delayed onset of effects leading to potential overdosing, and the risk of accidental ingestion by caregivers or household members. Clinicians caring for older adults should routinely inquire about cannabis use, including edible products, as part of medication reconciliation and should counsel patients on dose titration, potential drug interactions, and fall risk. For practitioners in states where cannabis is legal, this evidence suggests the need for geriatric-specific counseling and dosing guidelines to ensure safe and appropriate use in this vulnerable population.
“What we’re seeing in clinical practice is that older patients often find edibles preferable to smoking because they avoid respiratory irritation and provide more sustained symptom relief, but they frequently underestimate potency and onset time, which is why clear dosing education and realistic expectations about the 1-2 hour delay are essential before they use them.”
? As cannabis legalization expands, older adults represent a rapidly growing demographic of users, with edibles emerging as a preferred route of administration in this population. While older adults may choose edibles to avoid smoking-related respiratory risks or needle concerns, this route presents distinct clinical challenges including delayed onset of effects (which may encourage redosing), prolonged duration, and higher peak concentrations that increase fall risk, cognitive impairment, and drug interactions—concerns particularly salient in patients taking multiple medications or with polypharmacy. Clinicians should recognize that traditional counseling about cannabis may not address the specific motivations, preferences, and vulnerabilities of older patients, and that dosing guidance developed in younger populations may not translate safely to this age group. Given the limited geriatric safety data and the heterogeneity of edible products in unregulated markets, healthcare providers should proactively ask older patients about cannabis use during medication reviews, assess for
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
